NeuroDerm Rases Series A

NeuroDerm Ltd., an Ofakim, Israel-based developer of transdermal therapies for CNS diseases, has raised $2.5 million in Series A funding. Angel backers included Robert Taub, founder and CEO of Omrix Biopharmaceuticals. Prior seed backers included Ofakim High Tech Ventures. www.neuroderm.co.il